Tekla Capital Management LLC - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 88 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$933,000
+34.4%
155,9820.0%0.04%
+16.1%
Q1 2020$694,000
+6.8%
155,982
+128.1%
0.03%
+24.0%
Q4 2019$650,000–68,373–0.02%–
 Download
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders